Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure
Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure have?
Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure has 33 citations in the OpenAlex counts ScholarIQ stores.
When was Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure published?
Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure has 2022 year in the ScholarIQ index.
What is the open-access status of Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure?
Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure has gold oa status in the ScholarIQ index.
What is the DOI of Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure?
The DOI for Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure is on the source record.
What is the PMID of Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure?
The PMID for Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure is on the source record.
What is the OpenAlex record for Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure?
The OpenAlex for Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure is on the source record.